Irritable Bowel Syndrome (IBS): History and Discovery

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder — a condition of real, often disabling symptoms in which the bowel is structurally normal and shows no inflammation, ulceration, tumour, or other visible damage. Long before that idea was understood, the same cluster of cramping pain, bloating, and alternating diarrhoea and constipation was described under a parade of now-discarded names: mucous colitis, spastic colon, spastic colitis, nervous diarrhoea, colitis nervosa, nervous colon, and irritable colon. The word "colitis" in those labels turned out to be a misnomer — there is no "itis," no inflammation — and the twentieth century slowly replaced it with the term irritable bowel syndrome. This page traces that long road: from William Cumming's 1849 sketch of a fluctuating bowel, through the misleading "colitis" era, the influential mid-century studies, the symptom-based Manning criteria of 1978 and the iterative Rome criteria (1989 onward, through Rome IV in 2016), to the modern reframing of IBS as a disorder of gut–brain interaction. Where the historical record is uncertain, this page says so, and ideas that remain hypotheses are named as hypotheses.

What IBS Is — and Why Its History Is Confusing
The 19th Century: Cumming, "Mucous Colitis," and a Bowel Without a Lesion
The "Colitis" Misnomer and "Nervous" Names
From "Irritable Colon" to "Irritable Bowel Syndrome" (1929–1960s)
The Manning Criteria (1978): A Positive Diagnosis
The Rome Criteria (1989–2016): Building a Standard
A Disorder of Gut–Brain Interaction
Post-Infectious IBS, Visceral Hypersensitivity, and the Microbiome
Legacy: What the History Teaches
Research Papers and References
Connections

What IBS Is — and Why Its History Is Confusing

Irritable bowel syndrome is defined today by its symptoms, not by anything a pathologist can see down a microscope or an endoscopist can see through a scope. The cardinal features are recurrent abdominal pain linked to defecation and accompanied by a change in how often a person passes stool or in the form of that stool — harder, looser, or swinging between the two. Because the gut tissue itself looks normal, IBS is classed as a functional gastrointestinal disorder: the problem lies in how the bowel works and how it communicates with the nervous system, not in any structural lesion.

That single fact — symptoms without a visible cause — is exactly what makes the history of IBS so tangled. For most of medical history, a disease was only "real" if it left a mark a doctor could find: a stone, a growth, an ulcer, an inflamed and reddened lining. A bowel that produced suffering yet appeared healthy did not fit that model, so physicians reached for whatever framework was nearest to hand. At various times the same illness was filed under inflammation it did not have ("colitis"), under mucus it sometimes produced ("mucous colitis"), under muscle spasm ("spastic colon"), and under the nerves and the emotions ("nervous colon," "colitis nervosa").

Reading the old literature therefore requires care, and three things must be kept strictly apart. The first is the old names — the historical labels listed above, most of which are now abandoned. The second is the modern concept of a functional disorder of gut–brain interaction, which crystallised only in the twentieth and twenty-first centuries. The third is the diagnostic criteria — the Manning and Rome rule-sets that tell a clinician how to recognise IBS in a given patient. Confusing these three is the single commonest error in popular accounts of IBS history, and the sections that follow keep them separate on purpose.

Back to Table of Contents

The 19th Century: Cumming, "Mucous Colitis," and a Bowel Without a Lesion

Descriptions that we would today recognise as IBS reach back at least to the first half of the nineteenth century. The physician William Cumming, writing in 1849, gave one of the most frequently cited early accounts, capturing the maddening variability of the condition in a single line: the bowels, he observed, are "at one time constipated, at another lax, in the same person." That alternation between constipation and looseness in one individual is precisely the pattern modern medicine labels mixed-type IBS, and Cumming's description is regularly quoted in historical reviews as an early, clear portrait of the syndrome — though, as with all nineteenth-century sources, the absence of modern diagnostic tools means we cannot be certain every such patient had what we now call IBS rather than another, then-undetectable disease.

Later in the century the term "mucous colitis" came into use. Historical accounts attribute an influential description of mucous colitis to the great clinician William Osler around 1892, characterising patients — often described as nervous or highly strung — who passed mucus in the stool along with colicky pain. The name fused two observations that genuinely occurred in some sufferers (visible mucus and a "nervous" temperament) into a diagnosis. Its weakness was built into its second word: "colitis" asserts inflammation of the colon, and careful later study showed that most of these patients had no inflammation at all.

The deeper nineteenth-century difficulty was the lack of any way to look inside a living bowel without harm. There was no flexible colonoscope, no abdominal imaging, and no reliable means of distinguishing a functionally disturbed but healthy colon from one with early inflammatory bowel disease, a slow-growing tumour, or a chronic infection. A diagnosis of "mucous colitis" or "spastic colon" was therefore as much a confession of uncertainty as a statement of fact — a placeholder for a recognisable pattern of suffering whose mechanism nobody yet understood.

Back to Table of Contents

The "Colitis" Misnomer and "Nervous" Names

Through the late nineteenth and early twentieth centuries the same disorder accumulated a thicket of names, almost all of which we now know to be inaccurate. The inflammatory family — mucous colitis, spastic colitis, colitis nervosa — all carry the suffix "-itis," the medical marker of inflammation. The "nervous" family — nervous colon, nervous diarrhoea, colitis nervosa — tied the bowel trouble explicitly to the nerves, the emotions, and what the era called neurosis. A third strand, spastic colon and spastic colitis, located the problem in abnormal spasm of the colonic muscle.

The crucial twentieth-century correction was the recognition that "colitis" was a misnomer. As pathology and, later, endoscopy improved, it became clear that the great majority of patients carrying these labels had no inflammation of the bowel wall whatever — no ulceration, no inflammatory cells, no tissue damage. The word that had defined the diagnosis for decades described something that was not there. Keeping "colitis" in the name was not merely inelegant; it was actively misleading, because it implied a treatable inflammatory disease and risked confusion with the genuinely inflammatory conditions — ulcerative colitis and Crohn's disease — that share some symptoms but are entirely different illnesses.

The "nervous" names carried their own freight. By attributing the bowel symptoms primarily to neurosis or emotional weakness, they nudged the condition toward being dismissed as "all in the head" — a framing that stigmatised patients and slowed serious investigation. It is worth being careful here: the modern understanding does grant the nervous system and psychological state a real and central role in IBS, through the gut–brain axis described below. But that is a long way from the old implication that the suffering was imaginary or a sign of a weak character. The history of IBS terminology is, in large part, the slow disentangling of a genuine neuro-gastrointestinal mechanism from an unfair moral judgement.

Back to Table of Contents

From "Irritable Colon" to "Irritable Bowel Syndrome" (1929–1960s)

The vocabulary that would eventually win out began to surface in the early twentieth century. The phrase "irritable colon" appeared in the American literature around 1929, when Jordan and Kiefer used it to describe a disturbance of the colon's muscle and nerve function that they reported in a substantial fraction of gastroenterology outpatients. "Irritable" was a real improvement on "colitis": it made no false claim of inflammation, and it captured the sense of a bowel that overreacts — that is too easily provoked into cramping, urgency, and altered habit — which sits close to the modern idea of a hypersensitive, over-responsive gut.

Through the 1930s and 1940s the terms "irritable colon" and, increasingly, "irritable bowel" spread. Historical reviews place the emergence of the modern term "irritable bowel syndrome" in roughly this period — the 1940s through the 1960s — with several sources dating the term to around 1944 and crediting the physician P. W. Brown with popularising the "irritable bowel" concept in publications around 1947–1950. (Exact attribution of who first coined the precise three-word phrase is treated cautiously in the literature; the safe statement is that the term became established across these two decades, not that any single paper introduced it.) The shift from "colon" to "bowel" mattered too, since it acknowledged that the small intestine, not just the large, takes part in the disorder.

A landmark of this maturing era was the work of Chaudhary and Truelove in Oxford, whose influential 1962 study systematically described a large series of patients with the irritable colon syndrome. Their paper is repeatedly singled out in histories of IBS as a turning point: it brought careful, organised clinical observation to a condition that had been described loosely for a century, and — as discussed below — it also gave the first formal account of IBS arising after an episode of dysentery. By the time the Manning criteria appeared in 1978, "irritable bowel syndrome" was on its way to becoming the standard name, and the misleading "colitis" labels were in retreat.

Back to Table of Contents

The Manning Criteria (1978): A Positive Diagnosis

For most of its history, IBS was a diagnosis of exclusion: a doctor concluded a patient had it only after ruling everything else out, which left the diagnosis feeling like a shrug. The first serious attempt to turn that around — to let a clinician make a positive diagnosis from the pattern of symptoms themselves — came in 1978 with a short, influential paper by Manning, Thompson, Heaton, and Morris, published in the British Medical Journal under the apt title "Towards positive diagnosis of the irritable bowel." (The rule-set is universally known by the first author's name, the Manning criteria; Kenneth Heaton, the Bristol clinician later famous for the Bristol Stool Form Scale, was a co-author.)

The researchers questioned patients attending hospital with abdominal pain or a change in bowel habit and looked for symptoms that were significantly more common in those eventually diagnosed with IBS than in those found to have organic disease. A handful of features stood out and became the classic Manning symptoms: pain relieved by passing a bowel movement; looser stools at the onset of pain; more frequent stools at the onset of pain; visible abdominal distension (bloating); the passage of mucus; and a sensation of incomplete emptying. The more of these a patient reported, the more likely the diagnosis was IBS rather than something structural.

The importance of the Manning criteria lies less in the precise list than in the principle. They reframed IBS from "the thing left over when the tests are negative" into a condition with its own recognisable, positive symptom signature — one that could be studied, counted, and compared across patients and across hospitals. That move, treating a functional disorder as a definable clinical entity in its own right, set the stage directly for the more elaborate consensus criteria that followed in the 1980s and 1990s.

Back to Table of Contents

The Rome Criteria (1989–2016): Building a Standard

As interest in functional bowel disorders grew, the field needed a single, agreed yardstick rather than a scatter of local definitions. That effort became the Rome process, named for the city where the international working groups met, and it has produced successive editions of consensus diagnostic criteria that are now the global standard for IBS and its relatives. The lineage is layered, and the dates are worth getting right because popular accounts often blur them.

The first consensus product was the "Rome Guidelines" for IBS, published in 1989 by an international working team chaired by W. Grant Thompson, followed by a broader classification of functional gastrointestinal disorders around 1990. The refined IBS criteria known as Rome I appeared in 1992, and in 1994 the work was gathered into the first comprehensive book — The Functional Gastrointestinal Disorders — which is the volume now generally referred to as "Rome I." (This two-step history is why some sources date Rome I to 1992 and others to 1994: 1992 is the IBS criteria, 1994 is the book.) The Rome Foundation, the body that has organised the process ever since, was incorporated in 1996, with Douglas A. Drossman a central figure across the editions.

The criteria were then revised on a roughly decadal cycle, each edition tightening the symptom definitions and absorbing new evidence: Rome II in 1999, Rome III in 2006, and Rome IV in May 2016. Across these versions IBS came to be defined by recurrent abdominal pain related to defecation together with changes in stool frequency or form over a defined recent period, and the syndrome was sorted into subtypes by predominant stool pattern — constipation-predominant, diarrhoea-predominant, and mixed. The practical upshot is that the loose, century-old descriptive labels were replaced by a precise, reproducible, internationally shared definition — the framework summarised on this site's Rome IV subtypes page.

Back to Table of Contents

A Disorder of Gut–Brain Interaction

The most consequential conceptual shift came with Rome IV in 2016, which formally re-described the functional gastrointestinal disorders — IBS chief among them — as "disorders of gut–brain interaction" (DGBI). This was more than a change of label. The older phrase "functional disorder" told you what IBS was not (not structural, not inflammatory); the new phrase tried to say what it positively is — a disturbance in the constant two-way signalling between the digestive tract and the central nervous system.

Under this framework, the symptoms of IBS arise from some combination of altered gut motility, heightened sensitivity of the bowel to normal sensations (visceral hypersensitivity), changes in the gut lining and immune activity, shifts in the gut microbes, and altered processing of gut signals by the brain — all communicating along the gut–brain axis, the network of nerves (including the vagus nerve), hormones, and immune messengers that links the "second brain" of the gut's own nervous system to the brain proper. This model dignifies what the old "nervous colon" names had crudely gestured at: the nervous system really is deeply involved, but as a genuine biological circuit, not as a sign that the illness is imaginary.

It is important to flag what is settled and what is still being worked out. That IBS involves gut–brain dysregulation is now the mainstream framing and is well supported. But the precise weighting of the contributing mechanisms — how much is motility, how much is hypersensitivity, how much is microbial, how much is central — varies from patient to patient and remains an active research question. The DGBI concept is best understood as an organising model that has held up well, while several of its component mechanisms are still partly hypothesis. This page flags them as such rather than presenting any single mechanism as the proven cause of all IBS.

Back to Table of Contents

Post-Infectious IBS, Visceral Hypersensitivity, and the Microbiome

Several of the themes that dominate modern IBS research have surprisingly deep historical roots. The clearest is post-infectious IBS — the observation that a bout of gut infection can leave lasting IBS in its wake. The first formal description is again credited to Chaudhary and Truelove in 1962: in their Oxford series, about a quarter of patients reported that their symptoms had begun after an episode of bacillary or amoebic dysentery, and the authors coined the term "post-dysenteric" irritable colon for them. (An informal antecedent often cited is the unexplained chronic diarrhoea seen in British troops returning from the North African campaign of the Second World War after amoebic dysentery.) Modern epidemiology has confirmed and extended the finding: a significant minority of people develop persistent IBS after acute gastroenteritis, the basis of this site's post-infectious IBS page.

A second modern theme is visceral hypersensitivity — the finding that many people with IBS perceive ordinary gut events, such as the stretching of the bowel by gas or stool, as painful or urgent at volumes that would not trouble most people. This turns the old word "irritable" into a measurable phenomenon: the IBS gut is, in a real physiological sense, over-responsive. Visceral hypersensitivity, and its links to the brain's pain-processing pathways, is explored on the visceral hypersensitivity and brain–gut axis page; it is a leading explanation for IBS pain, though, like the other mechanisms, it accounts for some patients better than others.

The newest strand is the gut microbiome — the trillions of bacteria and other microbes living in the intestine. Research since the 2000s has linked altered microbial communities, and in some patients bacterial overgrowth of the small intestine, to IBS symptoms, connecting IBS to the closely related and sometimes overlapping condition of small intestinal bacterial overgrowth (SIBO). The microbiome story is genuinely new science and is evolving quickly; this page presents the association between the microbiome and IBS as an active and promising research area, not as a fully settled causal account. Taken together, post-infectious onset, visceral hypersensitivity, and the microbiome show how thoroughly the loose old picture of a "nervous" or "spastic" colon has been replaced by a layered, mechanistic, and still-unfolding understanding.

Back to Table of Contents

Legacy: What the History Teaches

The history of IBS is, above all, a lesson in the danger of naming a disease after a mechanism you have not actually demonstrated. For the better part of a century, "mucous colitis," "spastic colitis," and "colitis nervosa" built a false claim of inflammation into the very label, and the "nervous" names smuggled in a moral verdict that the suffering was imaginary. Each correction — dropping "colitis" because there was no inflammation, moving from "colon" to "bowel" because the small intestine is involved, and finally arriving at the neutral, accurate "irritable bowel syndrome" — was a small act of intellectual honesty about the limits of what was known.

The arc also shows how a vague clinical impression becomes rigorous medicine. Cumming's 1849 sketch of a fluctuating bowel, the careful mid-century series of Chaudhary and Truelove, the positive-diagnosis Manning criteria of 1978, the successive Rome consensus editions from 1989 to 2016, and the Rome IV reframing as a disorder of gut–brain interaction form a single, traceable line from anecdote to standardised, internationally agreed definition. Each step made IBS easier to study honestly, and each correction made the diagnosis less of a dustbin and more of a real, definable condition.

For anyone living with IBS today, the most humane part of this history is the rehabilitation of the patient. The condition once dismissed as "all in the head" is now understood as a genuine disorder of how the gut and brain talk to each other — real, common, biologically grounded, and worth taking seriously. The validation that the gut–brain framework offers, that the symptoms are not imagined and not a personal failing, is itself one of the quiet achievements of more than a century and a half of slowly getting the story right.

Back to Table of Contents

Research Papers and References

The list below combines key historical and review papers on irritable bowel syndrome with curated PubMed topic-search links into the diagnostic-criteria and history literature. Where a stable identifier is known, a direct DOI or PubMed link is given; otherwise a PubMed topic search is provided. Nineteenth- and early twentieth-century primary descriptions (Cumming 1849; Osler's "mucous colitis," c. 1892; Jordan and Kiefer's "irritable colon," 1929) are named in the article as historical sources rather than as modern citations. Each link opens at the National Library of Medicine in a new tab.

Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. British Medical Journal. 1978;2(6138):653–654. — PubMed PMID: 698649
Chaudhary NA, Truelove SC. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Quarterly Journal of Medicine. 1962;31:307–322. — PubMed: Chaudhary & Truelove irritable colon syndrome
Drossman DA, Hasler WL. Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150(6):1257–1261. — doi:10.1053/j.gastro.2016.03.035
Lacy BE, Mearin F, Chang L, et al. Bowel Disorders. Gastroenterology. 2016;150(6):1393–1407 (Rome IV). — doi:10.1053/j.gastro.2016.02.031
Mearin F, Lacy BE, Chang L, et al. (Rome IV bowel disorders, IBS criteria). — PubMed PMID: 27144627
Camilleri M. Diagnosis and Treatment of Irritable Bowel Syndrome: A Review. JAMA. 2021;325(9):865–877. — doi:10.1001/jama.2020.22532
Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. The Lancet. 2020;396(10263):1675–1688. — doi:10.1016/S0140-6736(20)31548-8
Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136(6):1979–1988. — doi:10.1053/j.gastro.2009.02.074
History and viewpoint on irritable bowel syndrome (historical review). — PubMed PMID: 2210186
The Rome process and the history of the diagnostic criteria for functional GI disorders. — PubMed: Rome criteria history
Manning criteria and the diagnosis of irritable bowel syndrome (validation studies). — PubMed: Manning criteria IBS diagnosis
Visceral hypersensitivity and the brain-gut axis in irritable bowel syndrome. — PubMed: visceral hypersensitivity brain-gut axis IBS
Gut microbiome and small intestinal bacterial overgrowth in irritable bowel syndrome. — PubMed: gut microbiome and SIBO in IBS
Disorders of gut-brain interaction (DGBI): concept and epidemiology. — PubMed: disorders of gut-brain interaction

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents